文献速递类风湿关节炎

美国类风湿关节炎患者阿片类药物使用趋势变化

Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States.
PubMed 文献 · Arthritis Rheumatol · 2017-08-13

该研究基于2006-2014年Medicare数据,分析97,859例类风湿关节炎(RA)患者规律使用阿片类药物的纵向趋势及风湿科医生处方差异。结果显示规律使用在2010年达峰后略降,丙氧芬撤市后氢可酮和曲马多使用增加;平均风湿科医生执业中40%的RA患者规律使用阿片类药物,医生间差异大。

要点

  • RA患者规律阿片使用2010年达峰后略降,丙氧芬撤市影响有限。
  • 平均风湿科医生中40%的RA患者规律使用处方阿片类药物。
  • 近半数患者至少部分阿片处方由风湿科医生开具,14%存在多医生同时处方。

核心结论

  • 美国老年RA患者阿片类药物使用在2010年达峰后略降,丙氧芬撤市对总体使用影响很小,因被其他阿片替代。

研究设计与样本

  • 基于2006-2014年Medicare数据识别97,859例RA患者,评估规律使用阿片类药物的纵向趋势,并单独分析2014年风湿科医生处方变异性。

主要发现

  • 最常用阿片为对乙酰氨基酚联合氢可酮或丙氧芬。
  • 规律阿片处方缓慢增加,在2010年丙氧芬撤市前达峰;撤市后氢可酮和曲马多使用相应增加,总体阿片使用仅略降。
  • 与规律使用阿片相关的因素包括较年轻年龄、女性、非裔美国人种族、背痛、纤维肌痛、焦虑和抑郁。
  • 美国风湿科医生(n=4,024)处方规律阿片使用变异性高;平均风湿科医生执业中40%的RA患者规律使用处方阿片。
  • 近半数患者至少部分阿片处方由风湿科医生开具,14%的患者同时接受超过1名医生共同处方的阿片。

临床怎么用

  • 风湿科医生应关注RA患者中阿片类药物的规律使用,尤其对较年轻、女性、非裔美国人及合并背痛、纤维肌痛、焦虑抑郁者。
  • 需注意多医生同时处方阿片的潜在风险,近半数患者部分阿片处方来自风湿科医生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Opioid prescribing recently has come under intense scrutiny. However, longitudinal patterns of prescription opioid receipt in a population-based cohort of patients with chronic pain, such as those with rheumatoid arthritis (RA), have not been well characterized. The aim of this study was to examine both trends over time and variability in individual physician prescribing of short-term and long-term use of opioids. METHODS: We identified a cohort of RA patients based on 2006-2014 Medicare data and evaluated longitudinal time trends in "regular" use of opioids. A separate analysis conducted in 2014 assessed rheumatologist-specific variability in regular use of opioid prescriptions in patients with RA. RESULTS: We identified 97,859 RA patients meeting the eligibility criteria. The mean age of the patients was 67 years, 80% were female, 82% were white, and 12% were African American. The most commonly used opioids were those that combined acetaminophen with hydrocodone or propoxyphene. Regular opioid prescribing increased slowly but peaked in 2010 before propoxyphene was withdrawn from the market. Following the withdrawal of propoxyphene, receipt of hydrocodone and tramadol increased commensurately, and overall opioid use declined only slightly. Factors associated with regular use of opioids included younger age, female sex, African American race, back pain, fibromyalgia, anxiety, and depression. Variability between US rheumatologists (n = 4,024) in prescribing the regular use of opioids for their RA patients was high; in the average rheumatologist's practice, 40% of RA patients used prescription opioids regularly. In almost half of the patients, at least some opioid prescriptions were written by a rheumatologist, and 14% received opioids that were co-prescribed concurrently by more than 1 physician. CONCLUSION: In the US, opioid use in older patients with RA peaked in 2010 and is now declining slightly. Withdrawal of propoxyphene from the US market in 2010 had minimal effect on overall opioid use, because use of propoxyphene was replaced by increased use of other opioids.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Curtis JR, Xie F, Smith C, et al. Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States. Arthritis Rheumatol. 2017. PMID: 28635179. doi:10.1002/art.40152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。